Development of AGS15E, a novel antibody drug conjugate targeting SLITRK6 for the treatment of bladder cancer.

被引：0
|
作者：
Morrison, Kendall [1 ]
机构：
[1] Agensys, Santa Monica, CA USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4332
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Development of a novel antibody-drug conjugate targeting endosialin/TEM-1: potent antitumor activity in sarcoma
    Sala, Gianluca
    Iacobelli, Stefano
    Capone, Emily
    PIccolo, Enza
    Sauniere, Jean-Fred
    Douet, Vanessa Vannucci
    CANCER RESEARCH, 2017, 77
  • [42] Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple Myeloma
    Springer, Aaron D.
    Wang, Rengang
    Wang, Jiawei
    Du, Qinyi
    Pi, Willie
    Nguyen, Austin Q.
    Li, Xiaoqing
    Khasanov, Alisher
    Zhu, Tong
    Yan, Zheng
    Hong, Yufeng
    Zhou, Heyue
    Zhang, Yanliang
    Kerwin, Lisa
    Li, Lingna
    Ji, Henry
    Zhang, Hong
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (10): : 2660 - 2672
  • [43] LCB97, an antibody drug conjugate (ADC) targeting a novel tumor antigen for the treatment of multiple solid tumors
    Jeong, Yeojin
    Spohn, Gunther
    Mehli, Flavio
    Chung, Chul-Woong
    Park, Changsik
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Development of novel bone targeting peptide-drug conjugate of 13-aminomethyl-15-thiomatrine for osteoporosis therapy
    Su, Jia
    Liu, Chao
    Bai, Haohao
    Cong, Wei
    Tang, Hua
    Hu, Honggang
    Su, Li
    He, Shipeng
    Wang, Yong
    RSC ADVANCES, 2021, 12 (01) : 221 - 227
  • [45] Development and evaluation of T-Zap: a novel antibody-drug conjugate for the treatment of Her2 positive breast cancer
    Hoffmann, Ricarda M.
    Crescioli, Silvia
    Thurston, David E.
    Karagiannis, Sophia N.
    CANCER RESEARCH, 2018, 78 (13)
  • [46] Development of a bispecific antibody-drug conjugate targeting EpCAM and CLDN3 for the treatment of multiple solid tumors
    Luo, Meiying
    Wang, Xiaohuan
    Yu, Guoji
    Ji, Jing
    Li, Long
    Song, Fan
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [47] 2 for 1: Targeting tumor-associated macrophages and cancer cells with a novel MERTK-targeting antibody-drug conjugate (ADC)
    Takeda, Shugaku
    Lo, PuiChi
    Schefer, Daniel
    Siddiqui, Maryam
    Tyagi, Anudishi
    Battula, Venkata Lokesh
    Maiti, Abhishek
    Tavazoie, Sohail
    Tavazoie, Masoud
    Darst, David Martin
    Kurth, Isabel
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [48] Development of AVID100, a novel antibody-drug conjugate for the treatment of EGFR expressing solid tumors
    O'Connor-McCourt, M.
    Koropatnick, J.
    Maleki, S.
    Figueredo, R.
    Tikhomirov, I.
    Jaramillo, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S147 - S147
  • [49] Development of a novel antibody-drug conjugate for the treatment of c-Kit expressing solid tumors and AML
    Abrams, Tinya J.
    Niu, Xiaohong
    Embry, Millicent
    Kline, Janine
    Patawaran, Montesa
    Fanton, Christie
    Ison-Dugenny, Marjorie
    Schneider, Tracy
    Miller, Kathy
    Wang, Zhen
    Ghoddusi, Majid
    Cohen, Steven
    Hong, E. Erica
    Lees, Emma
    Schleyer, Siew
    CANCER RESEARCH, 2015, 75
  • [50] Toward clinical development of SYD985, a novel HER2-targeting antibody-drug conjugate (ADC).
    Verheijden, Gijs
    Beusker, Patrick
    Ubink, Ruud
    van der Lee, Miranda
    Groothuis, Patrick
    Goedings, Peter J.
    Egging, David
    Mattaar, Ellen
    Timmers, Macro
    Dokter, Wim
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345